• Profile
Close

Comparative risk of new-onset diabetes mellitus for antihypertensive drugs: A network meta-analysis

The Journal of Clinical Hypertension Evidence based | Nov 14, 2017

Li Z, et al. - In this study, researchers compared antihypertensive drugs by identifying both the advantages and disadvantages on new-onset diabetes mellitus (NOD) by focusing on their respective effect rates. Findings demonstrated that with respect to NOD, angiotensin receptor blockers had an advantage over the other treatments.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay